Who We Are
Kinnate is a rapidly growing, clinical stage precision oncology company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. Kinnate’s mission is to expand the reach of targeted therapeutics by developing products for underserved populations. With our lead program currently conducting a Phase 1 clinical trial and another program expected to initiate a Phase 1 clinical trial in the first half of 2022 (subject to FDA clearance), it is a very exciting time to join Kinnate! In addition to the promising developments in our pipeline, Kinnate is financially strong with approximately $324.9 million of cash, cash equivalents and investments as of December 31, 2021, which is expected to fund current operations, including initiation of multiple registrational studies, into the second half of 2023. Based in San Francisco and San Diego, California, the Kinnate team is composed of drug discovery experts supported by a distinguished group of scientific advisors.
Kinnate is an employee-focused company providing a best-in-class benefits package which includes: cash salaries and bonuses and equity awards for all employees; employee stock purchase program; unlimited paid time off; annual paid “refresher” days for all employees; annual massage days for all employees; highly subsidized health benefits packages with a wide variety of provider options and minimal to no out of pocket expenses for employees; monthly stipend for employees who elect no health coverage through Kinnate; life and accidental death and disability insurance; company contribution to 401k plan; flexible office and remote work options; free local gym memberships; healthy lifestyle reimbursement program; home office reimbursement program; and commuter and walking/biking benefits. For more information, please visit www.kinnate.com.
Your impact at Kinnate
As the Director, Clinical Sciences you will be a critical member of our cross-functional teams contributing to the design & execution of clinical studies within Kinnate’s clinical programs. Your contributions will be foundational to the safe, efficient and compliant development of our next-generation targeted oncology therapies in early phase & advanced human clinical trials.
You will lead the collection, annotation, analysis and interpretation of clinical study data, while ensuring integration of PK, PD, biomarker and genomics data in partnership with R&D colleagues. You will also partner closely with Kinnate’s R&D team to develop early-phase clinical plans in support of successful IND submissions, lead development of clinical protocols, IBs and related plans and documents, and provide scientific expertise to internal teams and external partners in support of our programs.
You’ll leverage your thorough understanding of oncology drug development and your pro-active and highly developed communication skills to bring our innovative medicines to cancer patients.
New oncology therapy breakthroughs await your creative spirit and “roll-up your sleeves” approach because #patientsarewaiting
The Right Stuff
You have an advanced degree (eg MSc or PhD degree in health science field, a PharmD or Medical degree eg MD or MBBS).
You have a deep & sophisticated understanding of oncology drug development from pre-IND phases thru to early phase & late phase clinical development.
You have at least 10 years of experience in oncology R&D settings, much of which includes biopharma industrial experience.
You have at least 3 years of clinical research experience in the biopharma industry, preferably in oncology drug development programs
You have a deep working knowledge of ICH GCP guidelines, CFR, EMA, and HIPAA regulations
You have outstanding written & oral communication skills and presentation skills that enables clear messaging and drives programs forwardYou are recognized as a leader and have a track record of building strong collaborative partnership with diverse cross-functional team members & external partners
You are passionately committed to bring innovative oncology drugs to patients to drive better clinical outcomes.
NOTE: This position summary is not intended to be all-inclusive. Employee may perform other related duties as negotiated to meet the ongoing needs of the organization.
Kinnate is a science-driven company and we are proud to be responsible members of our communities. Subject to applicable law, we require all of our employees to be fully vaccinated and boosted against the COVID19 virus.
EEO & Employment Eligibility
Kinnate Biopharma Inc. is committed to building a diverse, equitable, and inclusive company. We provide equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Kinnate Biopharma Inc. also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of applicable law.
Recruitment & Staffing Agencies: Kinnate Biopharma Inc. does not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to Kinnate or its employees is strictly prohibited unless contacted directly by Kinnate’s internal HR Team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Kinnate, and Kinnate will not owe any referral or other fees with respect thereto.